Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

View All Documentation

PZ0383

Sigma-Aldrich

Palbociclib

≥98% (HPLC), powder, CDK 4 & 6 inhibitor

Synonyme(s) :

6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one, Ibrance, PD 0332991, PD 332991, PD-0332991, PD0332991, PD991, PF 00080665, PF-00080665, PF00080665

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C24H29N7O2
Numéro CAS:
571190-30-2
Poids moléculaire :
447.53
Code UNSPSC :
12352200
Nomenclature NACRES :
NA.77

product name

Palbociclib, ≥98% (HPLC)

Pureté

≥98% (HPLC)

Forme

powder

Couleur

white to beige

Solubilité

0.1 M HCl: 2 mg/mL, clear

Température de stockage

room temp

Chaîne SMILES 

CC(C1=C(N2C3CCCC3)N=C(NC4=CC=C(N5CCNCC5)C=N4)N=C1)=C(C(C)=O)C2=O

InChI

1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)

Clé InChI

AHJRHEGDXFFMBM-UHFFFAOYSA-N

Actions biochimiques/physiologiques

PF-00080665 (Palbociclib; PD 0332991) is an orally active and highly specific inhibitor against cyclin-dependent kinase 4 & 6 (IC50 = 9, 11, 15 nM, respectively, using CDK4/cycD3, CDK4/cycD1, CDK6/cycD2; IC50 >10 μM against 36 other kinases) that potently suppresses Cdk4/6-dependent cellular Rb phosphorylation (IC50 = 66 nM/pSer780 & 63 nM/pSer795; MDA-MB-435). PF-00080665 exhibits selective antiproliferation activity against Rb-positive human breast/colon/lung/leukemia cancer cultures (IC50 = 40-400 nM; IC50 >3 μM/Rb-negative MDA-MB-468 & H2009) and displays in vivo efficacy against various advanced stage human tumor xenografts in mice (12.5-150 mg/kg/day p.o.).

Stockage et stabilité

This chemical can be stored in solution at -80°C for 6 months and at -20°C for 1 month (protect from light).

Pictogrammes

Health hazardEnvironment
GHS08,GHS09

Mention d'avertissement

Warning

Mentions de danger

H341,H361f,H373,H411

Classification des risques

Aquatic Chronic 2 - Muta. 2 - Repr. 2 - STOT RE 2 Oral

Organes cibles

Bone marrow,male reproductive organs

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 7

1 of 7

Etoposide synthetic, 95.0-105.0%, powder

Sigma-Aldrich

E1383

Etoposide

Flavopiridol hydrochloride ≥98% (HPLC), powder

Sigma-Aldrich

F3055

Flavopiridol hydrochloride

Pazopanib

Sigma-Aldrich

CDS023580

Pazopanib

Roscovitine ≥98% (TLC)

Sigma-Aldrich

R7772

Roscovitine

Nilotinib

Sigma-Aldrich

CDS023093

Nilotinib

Dasatinib ≥98% (HPLC)

Sigma-Aldrich

SML2589

Dasatinib

Fulvestrant European Pharmacopoeia (EP) Reference Standard

Y0001413

Fulvestrant

Fiona J Ruiz et al.
Cancers, 13(18) (2021-09-29)
Cervical cancer tumors with undetectable HPV (HPVU) have been underappreciated in clinical decision making. In this study, two independent CC datasets were used to characterize the largest cohort of HPVU tumors to date (HPVU = 35, HPV+ = 430). Genomic
Xiaoyang Li et al.
Cell death & disease, 9(5), 446-446 (2018-04-20)
Synovial sarcoma is a highly aggressive but rare form of soft tissue malignancy that primarily affects the extremities of the arms or legs, for which current chemotherapeutic agents have not been proven to be very effective. The cyclin-dependent kinase 4/6-retinoblastoma
ER
Angel L Guerrero-Zotano et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 24(11), 2517-2529 (2018-03-28)
Shinya Kitamura et al.
Cancer science, 113(2), 802-807 (2021-12-07)
Extramammary Paget's disease (EMPD) is a rare adnexal neoplasm commonly seen in the genital areas among the senior population. The prognosis of advanced EMPD is not favorable; thus, the development of potential treatments has long been sought. Cyclin-dependent kinase (CDK)
Flora Doffe et al.
Cancers, 14(15) (2022-07-28)
The recent trend in 3D cell modeling has fostered the emergence of a wide range of models, addressing very distinct goals ranging from the fundamental exploration of cell-cell interactions to preclinical assays for personalized medicine. It is clear that no
Afficher tous les articles scientifiques apparentés

Contenu apparenté

Interrogation des voies protéiques

L'interrogation des voies protéiques est un élément fondamental de la recherche de nouveaux médicaments et de leur développement. Apprenez-en davantage sur l'analyse des voies protéiques, notamment le criblage de banques de composés chimiques, l'étude de l'activité des protéines et des enzymes, et la modulation des voies protéiques à l'aide de petites molécules.

Interrogation of Protein Pathways

Explore protein pathway analysis through chemical library screening, investigating protein interactions, and modulating signaling pathways with small molecules.

Interrogation of Protein Pathways

Explore protein pathway analysis through chemical library screening, investigating protein interactions, and modulating signaling pathways with small molecules.

Interrogation of Protein Pathways

Explore protein pathway analysis through chemical library screening, investigating protein interactions, and modulating signaling pathways with small molecules.

Afficher tout

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique